Thank you for the question.
In our situation, the relationship between the doctor and the patient is the main point. That said, often a doctor may prescribe something, and there is a generic drug on the market that is cheaper and gives you all the same attributes. Unless there's contradictory evidence, we go to the generic. If you had a national health care—and I never really thought about it, so I want to be careful what I say—I still think you would need that to ensure that you're getting the best cost for your dollar or bang for your buck. Therefore, you go to a generic first, and if it doesn't work, you go to the second or third order, and you get into what is best. I think my colleagues were talking about it earlier; they have the same thing in aboriginal.
I think any health care system, and even in pharmaceutical, the main point is the relationship between the doctor and the person. When you hit the pharmacy, you need checks and balances to ensure that if there is something more cost-effective...especially if we're talking $35 billion a year.